SAM-e for the Treatment of Depression in Patients With Parkinson's Disease

NCT00070941 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease
Depression

Interventions

DRUG: SAM-e
DRUG: oral escitalopram
DRUG: placebo

Sponsor

NYU Langone Health

Collaborators

[object Object]
[object Object]